C. Wasserheit

发表

Effect of highly active antiretroviral therapy on survival in patients with AIDS-associated pulmonary Kaposi's sarcoma treated with chemotherapy.

K. Takeshita, A. Chanan-Khan, B. Holkova, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A pilot study of dose-dense adjuvant paclitaxel without growth factor support for women with early breast carcinoma

D. Lake, C. Hudis, L. Norton, 2009, Breast Cancer Research and Treatment.

Tc‐99m LL‐2 fab' monoclonal antibody imaging in acquired immune deficiency syndrome‐related lymphoma

M. Volm, E. Kramer, B. Donahue, 1997, Cancer.

Cardiotoxicity and cardioprotection during chemotherapy.

H. Hochster, J. Speyer, C. Wasserheit, 1995, Current opinion in oncology.

Initial clinical evaluation of radiolabeled MX-DTPA humanized BrE-3 antibody in patients with advanced breast cancer.

R. Ceriani, J. Melamed, P. Furmanski, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase II trial of paclitaxel and cisplatin in women with advanced breast cancer: an active regimen with limiting neurotoxicity.

A. Zeleniuch‐Jacquotte, H. Hochster, A. Chachoua, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High‐Intensity Chemotherapy with Hematopoietic Support in Breast Cancer a

C. Hudis, L. Norton, P. Francis, 1993, Annals of the New York Academy of Sciences.

Effect o f H ighly A ctive A ntiretroviral T herapy o n S urvival in P atients W ith A IDS-Associated P ulmonary K aposi's Sarcoma T reated W ith C hemotherapy

K. Takeshita, A. Chanan-Khan, B. Holkova, 2001 .

Abnormal liver function in patients undergoing autologous bone marrow transplantation for hematological malignancies.

S. Gulati, C. Wasserheit, L. Acaba, 1995, Cancer investigation.

Purging in autologous and allogeneic bone marrow transplantation

T. Igarashi, R. Lemoli, S. Gulati, 1992, Current opinion in oncology.

Simultaneous dose escalation and schedule intensification of carboplatin-based chemotherapy using peripheral blood progenitor cells and filgrastim: a phase I trial.

L. Norton, J. Crown, M. Markman, 1994, Cancer research.

Taxanes in adjuvant and neoadjuvant therapies for breast cancer.

F. Muggia, J. O'Leary, M. Volm, 1998, Oncology.

Strategies for reduction of anthracycline cardiac toxicity.

J. Speyer, C. Wasserheit, 1998, Seminars in oncology.

Radiosensitization of tumor-targeted radioimmunotherapy with prolonged topotecan infusion in human breast cancer xenografts.

R. Ceriani, P. Furmanski, H. Hochster, 2001, Cancer research.

Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.

L. Norton, J. Crown, M. Moore, 1994, Bone marrow transplantation.

A phase I and pharmacokinetic study of docetaxel combined with Doxil (pegylated liposomal doxorubicin) without and with granulocyte colony stimulating factor

A. Pavlick, H. Hochster, F. Muggia, 2004, Anti-cancer drugs.

Phase I study of paclitaxel (P) combined with 14-day topotecan (T) Continuous IV (CIV) infusion in previously treated and untreated patients (PTS)

H. Hochster, A. Chachoua, J. Speyer, 1997 .